2-([1,1'-Biphenyl]-4-yl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde

Catalog No.: 
ACNXSK978
CAS No.: 
524724-71-8
Molecular Formula: 
C21H16N2O
Molecular Weight: 
312.37
2-([1,1'-Biphenyl]-4-yl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$182.00InquiryInquiry
1g97%$556.00InquiryInquiry
5g97%$2752.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-([1,1'-Biphenyl]-4-yl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde
IUPAC Name2-([1,1'-biphenyl]-4-yl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde
MDL No.MFCD03617280
Molecular FormulaC21H16N2O
Molecular Weight312.37
SMILESO=CC1=C(C2=CC=C(C3=CC=CC=C3)C=C2)N=C4C(C)=CC=CN41
InChI KeyWDDFLSHBGYDHNP-UHFFFAOYSA-N
Synonym2-BIPHENYL-4-YL-8-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE;Imidazo[1,2-a]pyridine-3-carboxaldehyde, 2-[1,1'-biphenyl]-4-yl-8-methyl-;2-([1,1'-Biphenyl]-4-yl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde
CAS No.524724-71-8

Synthetic Route by SureRoute

1. ACNXSK978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACNXSK978 route product structure diagram
    ACNXSK978524724-71-8
Inquiry

2. ACNXSK978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNXSK978 route product structure diagram
    ACNXSK978524724-71-8
Inquiry

3. ACNXSK978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNXSK978 route product structure diagram
    ACNXSK978524724-71-8
Inquiry

Comments (0)